Kevin Fischer, Brian Manuel

Genetic Technologies said in a document filed with the US Securities and Exchange Commission that Kevin Fischer has been appointed CFO, effective Nov. 2. He will replace Brian Manuel, who is leaving to pursue a personal business opportunity. Fischer has more than a decade of experience in senior finance roles at companies including Qiagen and Cellestis.